Liquid biopsy market to reach $11.3b by 2029

By clinical applications, therapy selection held the largest market share in 2023.

The global liquid biopsy market is expected to reach $11.3b at a compound annual growth rate (CAGR) of 11.9% until 2029.

A report by MarketsandMarkets revealed that the rising prevalence of cancer cases has driven the market’s growth, highlighting liquid biopsy as a non-invasive alternative for detection and monitoring.

By clinical applications, the therapy selection segment held the largest market share in 2023 fueled by the advantages of liquid biopsy over traditional methods.

ALSO READ: Gene panel market to reach $3.23b growth until 2027

Meanwhile, based on product and service, assay kits dominated the market in 2023 due to their adaptability to different biomarkers and analytes, accommodating the needs of liquid biopsy applications.

Such applications include the detection of circulating tumour DNA  and monitoring treatment response and disease progression.